Making laboratory testing more accessible
We create lower-cost consumables that can test multiple health parameters at the same time.
We create lower-cost consumables that can test multiple health parameters at the same time.
In places without healthcare infrastructure, patient follow-up is infrequent so the initial consult and having the correct information for a healthcare provider to make a decision is critical. Further, a majority of illnesses and diseases have treatment algorithms that require not only a PCR result, but potentially a measurement of the host response and general health of the patient. This is why multiomics and multimodal testing is a key driver in the platform solution that Fluxergy is developing.
Our goal is to provide as much diagnostic health information as possible per test that can be leveraged during the initial consult to expedite diagnosis and treatment. By decentralizing data collection via deployable platforms in community-based settings, we can aggregate more data at the population level to drive clinical decision making.
Fluxergy was created 10 years ago by Ryan Revilla and Tej Patel developing a working prototype analyzer and microfluidic cartridge system for HIV-1 testing out of their garage and apartment. Since Fluxergy has started, we have grown from a team of three in a garage to 100+ collaborating employees at Fluxergy’s technology and manufacturing campus totaling 70,000 sq. ft, cGMP-compliant and ISO/MDSAP certified. Fluxergy is expanding its technology to anywhere that lab testing can be better served including animal health, food safety, and forensics industries.
The platform technology we’ve developed enables us to understand our world and our health in ways which were never possible before
All the technologies we build are scalable and accessible. Reducing price barriers and democratizing laboratory testing is key to our future.
Our dream is to have every lab test you can imagine on a chip the size of your hand.
Doing more tests faster gives us the data we need, when we need it.
Information is empowering, especially when it comes to health and wellness. Better tools for collecting information for the diagnosis of illness and disease can help caregivers and patients make better point-of-care decisions.
Our mission is to help create a future where access to better tools for fast, accurate, and reliable biological metrics is commonplace and affordable, everywhere.
We believe in the power of innovation and creativity to produce impactful solutions for the challenges of sustaining a healthy planet. We believe that the democratization of access to timely and precise biological data will empower a holistic approach to OneHealth global care.
And, we believe we are all in this together. When we collaborate and share openly, the world is a better place.
The Fluxergy Analyzer platform combines the capabilities of many machines into one multimodal system, delivering more affordable laboratory-quality test results and actionable metrics in 60 minutes or less.
We will deliver fast, accurate, and reliable information on the spot – better data leads to better choices.
We’re making our platform accessible through a collaborative model which will enable us to provide a diverse portfolio of assays designed to meet the needs of communities and markets around the world.
We invite you to join us as a contributor to this effort.
Fluxergy’s Campus is 70,000 sqft and contains a state-of-the-art microfluidic manufacturing facility as well as technology excellence centers.
Our Manufacturing Center, 15 Musick
Our Research And Development Facility, 13766 Alton Pkwy
Our Corporate Headquarters, 30 Fairbanks
President and Co-Founder
Tej oversees various aspects of Fluxergy’s strategy, marketing, and technical development. Before co-founding Fluxergy, Tej worked at MagCanica, managing engineering projects for various clients including the US Navy, Mercedes-Benz F1, and Porsche. He holds a Bachelor’s degree in both Aerospace Engineering as well as Applied Mathematics, and a Master’s Degree in Aerospace Engineering with a specialization in fluid dynamics from the University of California, San Diego.
Vice President and Co-Founder
Ryan is responsible for leading manufacturing and technical development of Fluxergy’s products. Prior to co-founding Fluxergy, Ryan worked at MagCanica where he developed and managed several products for clients including Ferrari F1, RedBull F1, the US Air Force, GE Aviation, and United Technologies. He holds a Bachelor’s degree in Aerospace Engineering from the University of California, San Diego as well as a Master’s of Science from University of California, Los Angeles in Mechanical Engineering.
Chief Financial Officer and Co-Founder
Jonathan joined the Fluxergy team in 2013 and has been responsible for all financing activities, from budgets to the books. He also oversees operational management of the company’s day to day activities. Prior to joining Fluxergy, Jonathan was an Ambassador for the Bowers Museum foundation in Santa Ana. Jonathan holds a Bachelor’s in Business Administration from Chapman University in Southern California.
General Manager – Europe
Bernd is a seasoned venture capitalist with expertise in the global technology sector. He has funded startups in various industries and implements a hands-on approach to providing strategic corporate development. He currently works as a business development consultant for Kingston in Europe and is the executive director at Schnell Consult GmbH. He received his Dipl.- Kfm. from Goethe University in Management and Marketing.
Director of IT
Kung Sung is Fluxergy’s Director of IT, where he leads the team that connects Fluxergy through network and operating systems. He develops better business processes that monitors products from raw material to our customers. Kung received his Master of Science (M.S.) in Computer Engineering from California State University, Fullerton. Previously, he served as Senior Manager – Management Information Systems at Kingston Technology and as a consultant for Ernst and Young. He joined Fluxergy in 2020.
Director of Quality
Julie Manchester joined Fluxergy in April 2020. She oversees all quality and logistics operations. She has over 10 years in Quality Management and implementation of new Quality Systems at companies in the medical device, aerospace and testing industries. Prior to her role at Fluxergy as Director of Quality, Julie has worked as a Director of Quality and Regulatory Affairs at Tecan SP and The Hydrafacial Company, and as the Division Quality Manager at Element Materials Technology, who oversaw the entire Aerospace West Division that included 10 sites and 3 different countries. She holds a Bachelor’s Degree in Environmental Science from UC Riverside.
Associate Director, Molecular Assay Development
Dr. Pramod Naranatt brings 16 years of molecular IVD development across 3 platform technologies to Fluxergy. Pramod started his industry career at GenMark Dx taking the company’s first product to FDA 510(k). He has since been in various R&D roles, including, most recently as Director of R&D at Diasorin molecular. Pramod received his Ph.D. in molecular virology from ICMR – Reference Center for Viral Hepatitis at the University of Madras, India, and post-doctoral training from the University of Kansas Medical Center, KS. He oversees the molecular assay development team at Fluxergy.
Senior Director of Finance and Operations
Riaz Tootla joined Fluxergy in 2020 and has 15+ years of experience ranging from publicly traded Fortune 500 corporations to VC funded growth stage enterprises across various industries. Prior to joining Fluxergy he served in corporate finance roles at Honeywell, Kofax, and Kareo. Riaz holds a Bachelor’s degree in Business Administration from the University of Michigan, Stephen M. Ross School of Business.
CEO and Co-Founder of Kingston Technology
Lead Investor John Tu is co-founder and CEO of Kingston Technology, the world‘s biggest independent maker of computer memory products. The Fountain Valley, California-based company has four manufacturing sites worldwide producing memory modules for servers, computers and cameras, and had revenue of more than 10 billion in 2019. He has invested 50 million dollars into Fluxergy’s development.
Dr. Seidler is an experienced executive in the pharmaceutical, biopharmaceutical and vaccine industry with a strong focus in bringing innovative medicines to the market. He has a proven track record of building sustainable product pipelines from external and internal sources and has successfully developed and implemented R&D and business development strategies built around innovation, agility, profitability and quality.
Dr. Ali Tinazli joined Fluxergy from October 2019 to June 2021. As Chief Commercial Officer, he oversaw all commercial operations, strategic planning, business development, sales, and strategic partnerships. Prior to his role at Fluxergy, Dr. Ali Tinazli led the corporate-wide, global strategy for Healthcare and Life Sciences for Hewlett-Packard (HP Inc.). He received his Ph.D. in Biochemistry from J.W. Goethe University in Germany. After receiving his Ph.D., Ali worked in Corporate Development at Applied Biosystems (now: Thermo Fisher). He also currently serves as angel investor and board member at various start-ups ranging from cybersecurity to oncology.
Dr. Smith is a world-renowned thought-leader and researcher in HIV/AIDS research. He works both at the UCSD Antiviral Research Center and in his laboratory on the UCSD campus, where he performs bench research. His primary research focus is on the transmission of HIV, including HIV superinfection, molecular epidemiology and characterizing HIV shed from the genital tract. He also currently serves as the Head of UCSD’s Division of Infectious Diseases and Global Public Health, Vice-Chair of Research in UCSD’s Department of Medicine, and Co-Director of the San Diego Center for AIDS Research.
Dr. Witkoswki is an influential thought-leader in the field of Veterinary Medicine. He is currently an assistant professor at the Institute of Veterinary Medicine at the Warsaw University of Life Sciences, and an organizing committee member for the Annual Conferences of the Polish Equine Veterinary Association. His primary research focus is on the study of veterinary science with a focus in infectious diseases.